Clinical Trial Detail

NCT ID NCT04161885
Title A Study Evaluating Safety and Efficacy of Venetoclax in Combination With Azacitidine Versus Standard of Care After Allogeneic Stem Cell Transplantation (SCT) in Participants With Acute Myeloid Leukemia (AML) (VIALE-T)
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors AbbVie
Indications

acute myeloid leukemia

Therapies

Azacitidine + Venetoclax

Age Groups: adult child senior

No variant requirements are available.